Channing Capital Management LLC Has $84 Million Stake in Integer Holdings Co. (NYSE:ITGR)

Channing Capital Management LLC cut its holdings in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 2.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 633,880 shares of the medical equipment provider's stock after selling 12,935 shares during the period. Integer makes up approximately 2.2% of Channing Capital Management LLC's holdings, making the stock its 15th biggest position. Channing Capital Management LLC owned about 1.89% of Integer worth $84,002,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Mather Group LLC. lifted its position in shares of Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 143 shares in the last quarter. Huntington National Bank lifted its position in shares of Integer by 8,933.3% in the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider's stock valued at $35,000 after acquiring an additional 268 shares in the last quarter. R Squared Ltd purchased a new stake in Integer in the 4th quarter worth approximately $44,000. Versant Capital Management Inc lifted its position in Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock worth $49,000 after buying an additional 183 shares in the last quarter. Finally, Principal Securities Inc. lifted its position in Integer by 31.2% in the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock worth $85,000 after buying an additional 152 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Remove Ads

Integer Stock Performance

NYSE:ITGR traded down $0.64 during midday trading on Friday, reaching $117.76. The stock had a trading volume of 2,991,416 shares, compared to its average volume of 369,482. Integer Holdings Co. has a 1-year low of $107.11 and a 1-year high of $146.36. The firm's fifty day simple moving average is $134.43 and its 200-day simple moving average is $132.75. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The stock has a market capitalization of $3.96 billion, a P/E ratio of 35.05, a PEG ratio of 1.72 and a beta of 1.24.

Integer (NYSE:ITGR - Get Free Report) last posted its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.46 by ($0.03). Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. On average, equities research analysts forecast that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Analyst Ratings Changes

ITGR has been the subject of a number of research analyst reports. Benchmark increased their target price on shares of Integer from $140.00 to $150.00 and gave the stock a "buy" rating in a research report on Friday, February 21st. KeyCorp increased their target price on shares of Integer from $144.00 to $154.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Wells Fargo & Company reiterated an "overweight" rating and issued a $160.00 target price on shares of Integer in a research report on Tuesday, December 3rd. Oppenheimer downgraded shares of Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Finally, Truist Financial increased their price target on shares of Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a research note on Wednesday, December 11th. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $147.67.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.